Malaysia · Delayed Price · Currency is MYR Bioalpha Holdings Berhad Statistics
Total Valuation
KLSE:BIOHLDG has a market cap or net worth of MYR 21.29 million. The enterprise value is 9.30 million.
| Market Cap | 21.29M |
| Enterprise Value | 9.30M |
Important Dates
The next estimated earnings date is Friday, August 28, 2026.
| Earnings Date | Aug 28, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
KLSE:BIOHLDG has 1.42 billion shares outstanding. The number of shares has decreased by -0.07% in one year.
| Current Share Class | 1.42B |
| Shares Outstanding | 1.42B |
| Shares Change (YoY) | -0.07% |
| Shares Change (QoQ) | +19.23% |
| Owned by Insiders (%) | 15.98% |
| Owned by Institutions (%) | 13.76% |
| Float | 762.97M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.87 |
| PB Ratio | 0.33 |
| P/TBV Ratio | 0.58 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.82 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.47, with a Debt / Equity ratio of 0.06.
| Current Ratio | 3.47 |
| Quick Ratio | 2.85 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.92 |
| Interest Coverage | -131.43 |
Financial Efficiency
Return on equity (ROE) is -35.78% and return on invested capital (ROIC) is -59.89%.
| Return on Equity (ROE) | -35.78% |
| Return on Assets (ROA) | -21.67% |
| Return on Invested Capital (ROIC) | -59.89% |
| Return on Capital Employed (ROCE) | -46.33% |
| Weighted Average Cost of Capital (WACC) | 6.52% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.12 |
| Inventory Turnover | 3.24 |
Taxes
| Income Tax | -3.87M |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | 0.47 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 0.02 |
| 200-Day Moving Average | 0.02 |
| Relative Strength Index (RSI) | 54.84 |
| Average Volume (20 Days) | 320,525 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KLSE:BIOHLDG had revenue of MYR 11.39 million and -27.70 million in losses. Loss per share was -0.02.
| Revenue | 11.39M |
| Gross Profit | -27,751 |
| Operating Income | -31.72M |
| Pretax Income | -31.82M |
| Net Income | -27.70M |
| EBITDA | -28.86M |
| EBIT | -31.72M |
| Loss Per Share | -0.02 |
Balance Sheet
The company has 16.34 million in cash and 3.95 million in debt, with a net cash position of 12.38 million or 0.01 per share.
| Cash & Cash Equivalents | 16.34M |
| Total Debt | 3.95M |
| Net Cash | 12.38M |
| Net Cash Per Share | 0.01 |
| Equity (Book Value) | 65.37M |
| Book Value Per Share | 0.05 |
| Working Capital | 16.90M |
Cash Flow
In the last 12 months, operating cash flow was -3.82 million and capital expenditures -469,564, giving a free cash flow of -4.29 million.
| Operating Cash Flow | -3.82M |
| Capital Expenditures | -469,564 |
| Depreciation & Amortization | 2.86M |
| Net Borrowing | -894,358 |
| Free Cash Flow | -4.29M |
| FCF Per Share | -0.00 |
Margins
Gross margin is -0.24%, with operating and profit margins of -278.55% and -243.26%.
| Gross Margin | -0.24% |
| Operating Margin | -278.55% |
| Pretax Margin | -279.47% |
| Profit Margin | -243.26% |
| EBITDA Margin | -253.44% |
| EBIT Margin | -278.55% |
| FCF Margin | n/a |
Dividends & Yields
KLSE:BIOHLDG does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.07% |
| Shareholder Yield | 0.07% |
| Earnings Yield | -130.08% |
| FCF Yield | -20.16% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on December 6, 2016. It was a forward split with a ratio of 1.0117668484.
| Last Split Date | Dec 6, 2016 |
| Split Type | Forward |
| Split Ratio | 1.0117668484 |
Scores
KLSE:BIOHLDG has an Altman Z-Score of 0.07 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.07 |
| Piotroski F-Score | 3 |